• Mon, October 10, 2022

Joseph Pantginis Initiated (APRE) at Strong Buy and Held Target at $60 on, Oct 10th, 2022

Joseph Pantginis of HC Wainwright & Co., Initiated "Aprea Therapeutics, Inc." (APRE) at Strong Buy and Held Target at $60 on, Oct 10th, 2022.

Joseph has made no other calls on APRE in the last 4 months.



There is 1 other peer that has a rating on APRE. Out of the 1 peers that are also analyzing APRE, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Robert Driscoll of "Wedbush" Initiated at Buy and Held Target at $60 on, Friday, July 8th, 2022

Like: 👍